Ablation Technology Market by Type (Radiofrequency Ablation, Laser/Light Ablation, Ultrasound Ablation, Electrical Ablation, Cryoablation, Microwave Ablation, and Hydrothermal Ablation), Product (Radiofrequency Ablators, Laser/Light Ablators, Ultrasound Ablators, Electrical Ablators, Cryoablation Devices, Microwave Ablators, and Hydrothermal Ablators), Application (Cardiovascular Disease Treatment, Cancer Treatment, Ophthalmologic Treatment, Pain Management, and Others): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00027011 | Pages: 100 | Industry: Medical Device | Date: Oct 2022 | Type: Global

The market crossed US$ 5.7 billion mark in 2022 and is expected to hit US$ 11.55 billion by 2030, recording a CAGR of 9.06% during the forecast period.  

Cardiovascular disease treatment segment held the largest share by application segment.

Based on the application, the ablation technology market is segmented into cardiovascular disease treatment, cancer treatment, ophthalmologic treatment, pain management, and others. The cardiovascular disease treatment segment held the largest share in the global ablation technology market in 2022, however, the cancer treatment segment is expected to record significant growth.

Within the report, the market is segmented into type, product, application, and geography. By type, the market is further segmented into radiofrequency ablation, laser/light ablation, ultrasound ablation, electrical ablation, cryoablation, microwave ablation, and hydrothermal ablation. Based on product, the market is segmented into radiofrequency ablators, laser/light ablators, ultrasound ablators, electrical ablators, cryoablation devices, microwave ablators, and hydrothermal ablators. Based on application, the market is segmented into cardiovascular disease treatment, cancer treatment, ophthalmologic treatment, pain management, and others. Geographically, the market is subsegmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Get more information on this report :

Growing demand for minimally invasive/non-invasive procedures

An ablation refers to the surgical removal of a body tissue in the form of transferring heat to the target tissue. This process is used to remove tiny or large quantity of tissue. Biological ablation is the removal of biological structure or functionality.

A minimally invasive medical procedure is generally carried out by inserting a small device or an implant in body through an incision or anatomical opening. The popularity of these procedures has increased in the recent years due to the involvement of tiny incisions, faster recovery of patients, and less discomfort caused to the patients. Moreover, these procedures are also associated with benefits such as less trauma to muscles, nerves, tissues, and organs; less bleeding and scarring; and minimal injuries to tissues and less pain. The growing prevalence of arthritis, cancer, and cardiovascular diseases, all of which require extensive surgical treatments, has boosted demand for minimally invasive procedures that widely uses ablation technology as treatment.

Rising prevalence of cardiovascular diseases (CVD) is one of the major factors accelerating the market growth.

The growing prevalence of cardiovascular diseases (CVDs) such as coronary heart diseases, sudden cardiac arrest, congenital heart diseases, heart failure, pulmonary hypertension, and pulmonary artery pressure (PA) is encouraging the introduction of improved ablation technology. According to the World Health Organization (WHO), ~30 million people experience a stroke each year. Moreover, the American Heart Association states more than 130 million people in the US, i.e., 45.1% of the population, are projected to have a type of CVD by 2035.  Rising prevalence of cardiovascular diseases (CVD) and technological advancement in this field will boost market growth

Recent strategic developments in ablation technology market

The ablation technology market has undergone several significant developments, and a few of these have been mentioned below:

  • In September 2022, Stryker announced that its OptaBlate bone tumor ablation system received 510(k) clearance from the U.S. Food and Drug Administration. The addition of the OptaBlate technology to Stryker's Interventional Spine (IVS) portfolio expanded its core competencies in vertebral augmentation and radiofrequency ablation and completed its portfolio of treatment options for metastatic vertebral body fractures.
  • In August 2022, Thermedical received US Food and Drug Administration (FDA) approval for a clinical trial of its Saline Enhanced Radiofrequency (SERF) Ablation System.
  • In June 2021, Boston Scientific Corporation acquired the remaining shares of Farapulse, Inc. The acquisition complemented the existing Boston Scientific electrophysiology portfolio to include the FARAPULSE Pulsed Field Ablation (PFA) System – a non-thermal ablation system for treating atrial fibrillation (AF) and other cardiac arrhythmias.

The ablation technology market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. AngioDynamics, Inc., AtriCure, Inc., Biosense Webster, Inc. (Johnson & Johnson Inc.), Boston Scientific Corporation, BTG International Ltd., Conmed Corporation, Medtronic PLC, Olympus Corporation, Smith & Nephew, and St. Jude Medical, Inc. are among the prominent players operating in the market. 

Target audience for the report:

  • Laser/light ablators providers
  • Electrical ablators providers
  • Ultrasound ablators providers
  • Cryoablation devices providers
  • Associations, organizations, forums, and alliances
  • Government bodies, such as regulating authorities and policy makers
  • Venture capitalists, private equity firms, and start-up companies
  • Microwave ablators component suppliers
  • Hydrothermal ablator distributors and sales firms
  • End users of ablation technology
  • Research institutes, organizations, and consulting companies      

Scope of the report:

In this report, the market has been segmented based on:

  • Type:
    • Radiofrequency Ablation
    • Laser/Light Ablation
    • Ultrasound Ablation
    • Electrical Ablation
    • Cryoablation
    • Microwave Ablation
    • Hydrothermal Ablation
  • Product
    • Radiofrequency Ablators
    • Laser/Light Ablators
    • Ultrasound Ablators
    • Electrical Ablators
    • Cryoablation Devices
    • Microwave Ablators
    • Hydrothermal Ablators
  • Application:
    • Cardiovascular Disease Treatment
    • Cancer Treatment
    • Ophthalmologic Treatment
    • Pain Management
    • Others
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • AngioDynamics, Inc.
    • AtriCure, Inc.
    • Biosense Webster, Inc. (Johnson & Johnson Inc.)
    • Boston Scientific Corporation
    • BTG International Ltd.
    • Conmed Corporation
    • Medtronic PLC
    • Olympus Corporation
    • Smith & Nephew
    • St. Jude Medical, Inc.

The List of Companies
- AngioDynamics, Inc.
- AtriCure, Inc.
- Biosense Webster, Inc. (Johnson & Johnson Inc.)
- Boston Scientific Corporation
- BTG International Ltd.
- Conmed Corporation
- Medtronic PLC
- Olympus Corporation
- Smith & Nephew
- St. Jude Medical, Inc.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$1500
Site License
$2500
Enterprise License
$3500